These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 20930455)

  • 1. Telmisartan and obesity.
    Fernández-Fernández FJ
    Intern Med; 2010; 49(19):2191; author reply 2193. PubMed ID: 20930455
    [No Abstract]   [Full Text] [Related]  

  • 2. Angiotensin II receptor blocker telmisartan enhances running endurance of skeletal muscle through activation of the PPAR-δ/AMPK pathway.
    Feng X; Luo Z; Ma L; Ma S; Yang D; Zhao Z; Yan Z; He H; Cao T; Liu D; Zhu Z
    J Cell Mol Med; 2011 Jul; 15(7):1572-81. PubMed ID: 20477906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telmisartan activates endogenous peroxisome proliferator-activated receptor-δ and may have anti-fibrotic effects in human mesangial cells.
    Mikami D; Kimura H; Kamiyama K; Torii K; Kasuno K; Takahashi N; Yoshida H; Iwano M
    Hypertens Res; 2014 May; 37(5):422-31. PubMed ID: 24352213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive deficit in amyloid-beta-injected mice was improved by pretreatment with a low dose of telmisartan partly because of peroxisome proliferator-activated receptor-gamma activation.
    Tsukuda K; Mogi M; Iwanami J; Min LJ; Sakata A; Jing F; Iwai M; Horiuchi M
    Hypertension; 2009 Oct; 54(4):782-7. PubMed ID: 19635982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telmisartan increases adiponectin levels: a meta-analysis and meta-regression of randomized head-to-head trials.
    Takagi H; Umemoto T
    Int J Cardiol; 2012 Mar; 155(3):448-51. PubMed ID: 22192290
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma renin activity for predicting antihypertensive drug efficacy.
    Blumenfeld JD
    Am J Hypertens; 2008 Jan; 21(1):5-6. PubMed ID: 18091734
    [No Abstract]   [Full Text] [Related]  

  • 7. Telmisartan prevents obesity and increases the expression of uncoupling protein 1 in diet-induced obese mice.
    Araki K; Masaki T; Katsuragi I; Tanaka K; Kakuma T; Yoshimatsu H
    Hypertension; 2006 Jul; 48(1):51-7. PubMed ID: 16717145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telmisartan, an angiotensin II type-1 receptor blocker, improved insulin resistance in a schizophrenic patient treated with olanzapine: a case report.
    Yamashita H; Yoda H; Maruki T; Toyoshima R
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):308-10. PubMed ID: 17884270
    [No Abstract]   [Full Text] [Related]  

  • 9. Does the angiotensin receptor blocker telmisartan prevent morbid atherosclerotic events?
    Cohn JN
    Nat Clin Pract Cardiovasc Med; 2008 Sep; 5(9):526-7. PubMed ID: 18665135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of telmisartan added to Angiotensin-converting enzyme inhibitors on mortality and morbidity in hemodialysis patients with chronic heart failure a double-blind, placebo-controlled trial.
    Cice G; Di Benedetto A; D'Isa S; D'Andrea A; Marcelli D; Gatti E; Calabrò R
    J Am Coll Cardiol; 2010 Nov; 56(21):1701-8. PubMed ID: 21070920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The insulin sparing effect of telmisartan in a case of type 2 diabetes mellitus associated with schizophrenia under treatment of risperidone.
    Yamaguchi K; Tsutsumi E
    Intern Med; 2010; 49(10):919-23. PubMed ID: 20467177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urine Eicosanoids in the Metabolic Abnormalities, Telmisartan, and HIV Infection (MATH) Trial.
    Le CN; Hulgan T; Tseng CH; Milne GL; Lake JE
    PLoS One; 2017; 12(1):e0170515. PubMed ID: 28118376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of telmisartan plus amlodipine in the treatment of hypertension: review of results.
    Oigman W; Neves MF; Gismondi RA
    Expert Rev Cardiovasc Ther; 2010 Nov; 8(11):1509-17. PubMed ID: 21090924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telmisartan attenuates hepatic fibrosis in bile duct-ligated rats.
    Yi ET; Liu RX; Wen Y; Yin CH
    Acta Pharmacol Sin; 2012 Dec; 33(12):1518-24. PubMed ID: 23103625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telmisartan treatment attenuates arsenic-induced hepatotoxicity in mice.
    Fouad AA; Al-Mulhim AS; Jresat I
    Toxicology; 2012 Oct; 300(3):149-57. PubMed ID: 22750630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renoprotective effect of telmisartan in patients with chronic kidney disease.
    Nakamura T; Inoue T; Sugaya T; Kawagoe Y; Suzuki T; Ueda Y; Node K
    Clin Exp Hypertens; 2008 Oct; 30(7):662-72. PubMed ID: 18855269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Telmisartan (micardis) -- an antagonist of angiotensin 2 of type 1 receptors: another antihypertensive drug or something greater?].
    Chazova IE
    Ter Arkh; 2003; 75(6):89-91. PubMed ID: 12920969
    [No Abstract]   [Full Text] [Related]  

  • 18. Combined blockade of angiotensin II type 1 receptor and activation of peroxisome proliferator-activated receptor-γ by telmisartan effectively inhibits vascularization and growth of murine endometriosis-like lesions.
    Nenicu A; Körbel C; Gu Y; Menger MD; Laschke MW
    Hum Reprod; 2014 May; 29(5):1011-24. PubMed ID: 24578472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Efficacy of Long-term Oral Treatment with Telmisartan and Benazepril in Cats with Chronic Kidney Disease.
    Sent U; Gössl R; Elliott J; Syme HM; Zimmering T
    J Vet Intern Med; 2015; 29(6):1479-87. PubMed ID: 26474314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nifedipine and telmisartan for the treatment of hypertension: the TALENT study.
    Derosa G; Maffioli P
    Expert Rev Cardiovasc Ther; 2011 Dec; 9(12):1499-503. PubMed ID: 22103868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.